Login

MOMENTA PHARMACEUTICALS INC 3 SEC Filings

Filed On Filing
15 Jan 2020 Form 3: Cieplinska Agnieszka, VP FINANCE, CONTROLLER (PAO)
13 Dec 2019 Form 3: Barlow Jane F, Director

No securities owned

20 Sep 2019 Form 3: Grogan Donna Roy, Director

No securities owned

11 Oct 2018 Form 3: Beltramello Jo Ann, Chief HR and Inf. Officer

Holds 135,038 shares of Common Stock

11 Oct 2018 Form 3: Carvajal Alejandra, Chief Legal Officer

Holds 8,749 shares of Common Stock

11 Oct 2018 Form 3: Carvajal Alejandra, Chief Legal Officer

Holds 8,749 shares of Common Stock

11 Oct 2018 Form 3: Fier Ian, Chief Mfg and Program Officer

Holds 80,485 shares of Common Stock

11 Oct 2018 Form 3: Fier Ian, Chief Mfg and Program Officer

Holds 80,485 shares of Common Stock

11 Oct 2018 Form 3: Manning Anthony M., Chief Scientific Officer

Holds 62,406 shares of Common Stock

11 Oct 2018 Form 3: Robertson Michelle, Chief Financial Officer

Holds 8,769 shares of Common Stock

12 Mar 2018 Form 3: Kwon Young, SVP, Corporate Development

Holds 142,411 shares of Common Stock

01 Jun 2017 Form 3: Arroyo Santiago, SVP, Chief Medical Officer

No securities owned

07 Dec 2016 Form 3: Storer Scott M, SVP, CFO

No securities owned

23 Sep 2016 Form 3: Fishman Corey N., Director

No securities owned

24 Jun 2016 Form 3: Gilman Steven C, Director

No securities owned

10 Mar 2016 Form 3: Guiterrez-Ramos Jose Carlos, Director

No securities owned

05 Jan 2016 Form 3: Gemayel Georges, Director

Holds 4,000 shares of Common Stock

14 Dec 2015 Form 3: Ottmer Matthew P., Chief Operating Officer

No securities owned

12 Dec 2013 Form 3: Franken Michael, President, Biosimilars Busines

No securities owned

24 Jan 2011 Form 3: Koestler Thomas P, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support